Reducing the Nonindicated Use of IV Hydralazine in the Inpatient Setting

Nonindicated IV hydralazine use decreased from 69% to 25%. Order set modifications had a greater impact than education alone. Embedding decision support with targeted education offers a scalable, reproducible model for safer inpatient prescribing.

Authors

John B. Lynch (ORCID: https://orcid.org/0000-0001-9018-8542)
Jennifer Baldwin (ORCID: https://orcid.org/0000-0001-7830-7270)
Ashwin Kumar

Institutions

UConn Health (US)

Publication Details

Journal: JACC Case Reports
Published: 2025-10-07
DOI: https://doi.org/10.1016/j.jaccas.2025.105712
Primary Topic: Antibiotic Use and Resistance
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Reducing the Nonindicated Use of IV Hydralazine in the Inpatient Setting

John B. Lynch, Jennifer Baldwin, Ashwin Kumar

Oct 7, 2025

JACC Case Reports

Antibiotic Use and Resistance

article

Reducing the Nonindicated Use of IV Hydralazine in the Inpatient Setting

John B. Lynch, Jennifer Baldwin, Ashwin Kumar

October 7, 2025article en

Abstract

JACC Case ReportsVol. 30(36)

UConn Health (US)

Openalex Percentile: Top 66%

Antibiotic Use and Resistance

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Reducing the Nonindicated Use of IV Hydralazine in the Inpatient Setting — John B. Lynch, Jennifer Baldwin, et al. · JACC Case Reports (2025) | TGRS Research Map | TGRS